-
Study aim
-
The aim of the current study is to fabricate a customized biocompatible 3D printed scaffold and use in combination with BFP- SVF for human alveolar cleft reconstruction.
-
Design
-
Phase 1 of clinical trial with control group and one-sided blind with no randomization on 10 patients
-
Settings and conduct
-
Patients referred to Ayatollah Taleghani Hospital (Tehran, Iran) are selected according to the inclusion and exclusion criteria. By an experienced oral and maxillofacial surgeon and under general anesthesia the test patients are treated by the 3D printed customized scaffold with buccal fat pad micro graft, and the control patients by autogenous iliac bone graft. CBCT images obtained 6 months after the surgery are evaluated by an experienced blind radiologist.
-
Participants/Inclusion and exclusion criteria
-
The inclusion criteria include:
1. patient with alveolar or palatal cleft,
2. Defect size more than 2 cm3,
3. Soft tissue deficiency is not seen,
4. Maxillary sinus is not involved,
5. Dental dehiscence or fenestration is not seen.
The exclusion criteria include:
1. Autoimmune or metabolic or systemic diseases
2. Peripheral vascular diseases,
3. Marble bone disease or osteoporosis,
4. Smoking or alcohol consumption,
5. Conditions which compromise wound healing process,
6. Being in breastfeeding or pregnancy.
-
Intervention groups
-
1. Alveolar cleft treated by the 3D printed composite scaffold with buccal fat pad micrograft
2. Alveolar cleft treated by autogenous iliac bone graft
-
Main outcome variables
-
In the previous cleft region, height, width, and length of the alveolar ridge, newly formed bone density, bone to construct contact are evaluated. In histologic analysis, the rate of new bone formation, the rate of fibrosis or necrosis (if seen), foreign body reaction (if seen), and the rate of remained scaffold are evaluated.